These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 16627554

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
    Jiang JL, Jiang DJ, Tang YH, Li NS, Deng HW, Li YJ.
    Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, interacts with gastric oxidative metabolism and enhances stress-induced gastric lesions.
    Kwiecien S, Ptak-Belowska A, Krzysiek-Maczka G, Targosz A, Jasnos K, Magierowski M, Szczyrk U, Brzozowski B, Konturek SJ, Konturek PC, Brzozowski T.
    J Physiol Pharmacol; 2012 Oct; 63(5):515-24. PubMed ID: 23211305
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.
    Xiong Y, Lei M, Fu S, Fu Y.
    Life Sci; 2005 May 27; 77(2):149-59. PubMed ID: 15862600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
    Böger GI, Rudolph TK, Maas R, Schwedhelm E, Dumbadze E, Bierend A, Benndorf RA, Böger RH.
    J Am Coll Cardiol; 2007 Jun 12; 49(23):2274-82. PubMed ID: 17560293
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH.
    Clin Chem Lab Med; 2003 Nov 12; 41(11):1467-72. PubMed ID: 14656027
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML.
    J Affect Disord; 2004 Jun 12; 80(2-3):249-56. PubMed ID: 15207938
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications.
    Yamagishi S, Ueda S, Nakamura K, Matsui T, Okuda S.
    Curr Pharm Des; 2008 Jun 12; 14(25):2613-8. PubMed ID: 18991678
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of ADMA (asymmetric dimethylarginine) on physiology with respect to diabetes mellitus and respiratory system BEAS-2B cells (human bronchial epithelial cells).
    Galal O, Podlogar J, Verspohl EJ.
    J Pharm Pharmacol; 2013 Feb 12; 65(2):253-63. PubMed ID: 23278693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.